European Commission Approves New Intravenous Formulation Of Pfizer s … - Phramalive.com
Revatio is Only PAH Treatment in Its Class with Approved I.V. Formulation, Allowing Patients to Continue Treatment While Unable to Use Oral Therapy NEW YORK–(BUSINESS WIRE)–Pfizer Inc. announced today that the European Commission has approved …
